Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slove-nian real-world data. Radiol Oncol. 2026;60(2):288-293. Accessed September 22, 2026. https://www.radioloncol.com/index.php/ro/article/view/4731